Abstract
Fetal life is one of the critical periods when an exposure may have lifelong effects through biological programming. Intrauterine exposure to an excess of fuels, such as hyperglycemia, leads to greater birth weight and an increased risk of obesity, impaired glucose tolerance, and type 2 diabetes. These effects are not limited to children of women diagnosed with diabetes. In addition to hyperglycemia, alterations in other maternal fuels or derangement in placental transport of fuels may be involved in fetal overgrowth. Obesity is a major risk factor for diabetes and studies have shown an independent association of maternal obesity with excessive fetal growth and adiposity. Several mechanisms that are not mutually exclusive may explain these associations, including: genetic predisposition, shared familial socioeconomic and lifestyle factors, and specific intrauterine effects. Future research should further characterize the specific intrauterine mediators of short and long-term consequences, and provide better understanding of the biological bases of fetal programming. Such studies could ultimately lead to the development of strategies for early life prevention of future chronic disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hussain A, Claussen B, Ramachandran A, Williams R. Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract. 2007;76:317-326.
Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin North Am. 1999;28(9):709-729.
Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diab Care. 2005;28:579-584.
Ferrarra A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol. 2004; 103:526-533.
Sobngwi E, Boudou P, Mauvais-Jarvis F. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet. 2003;361:1861-1865.
Pedersen J. Weight and lenght at birth in infants of diabetic mothers. Acta Endocrinol. 1954;16:330-342.
Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980;29:1023-1035.
Whitaker RC, Dietz WH. Role of the prenatal environment in the development of obesity. J Pediatr. 1998;132:768-776.
Barker DJ, Fall CH. Fetal and infant origins of cardiovascular disease. Arch Dis Child. 1993;68:797-799.
Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life [see comments]. Lancet. 1993;341:938-941.
Barker DJ. In utero programming of chronic disease. Clin Sci (Colch ). 1998;95:115-128.
Aerts L, Sodoyez-Goffaux F, Sodoyez JC, Malaisse WJ, Van Assche FA. The diabetic intrauterine milieu has a long-lasting effect on insulin secretion by B cells and on insulin uptake by target tissues. Am J Obstet Gynecol. 1988;159:1287-1292.
Gauguier D, Nelson I, Bernard C. Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes. 1994;43:220-224.
Lampl M, Jeanty P. Exposure to maternal diabetes is associated with altered fetal growth patterns: A hypothesis regarding metabolic allocation to growth under hyperglycemic-hypoxemic conditions. Am J Hum Biol. 2004;6:237-263.
Jansson T, Cetin I, Powell TL. Placental transport and metabolism in fetal overgrowth — a workshop report. Placenta. 2006;27(suppl A):S109-S113.
Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698-1704.
Perry IJ, Lumey LH. In: Kuh D, Ben-Shlomo Y, eds. A Life Course Approach to Chronic Disease Epidemiology. Oxford: Oxford University Press; 2004:345.
Luke B. Nutritional influences on fetal growth. Clin Obstet Gynecol. 1994;37:538-549.
Abrams BF, Berman CA. Nutrition during pregnancy and lactation. Prim Care. 1993;20:585-597.
Vohr BR, McGarvey ST, Coll CG. Effects of maternal gestational diabetes and adiposity on neonatal adiposity and blood pressure. Diabetes Care. 1995;18:467-475.
Vohr BR, McGarvey ST. Growth patterns of large-for-gestational-age and appropriate-for-gestational-age infants of gestational diabetic mothers and control mothers at age 1 year. Diabetes Care. 1997;20:1066-1072.
Catalano PM, Kirwan JP. Maternal factors that determine neonatal size and body fat. Curr Diab Rep. 2001;1:71-77.
Ouzilleau C, Roy MA, Leblanc L, Carpentier A, Maheux P. An observational study comparing 2-hour 75-g oral glucose tolerance with fasting plasma glucose in pregnant women: both poorly predictive of birth weight. CMAJ. 2003;168:403-409.
Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003; 133:1674S–1683S.
Brown JE, Potter JD, Jacobs DR Jr. Maternal waist-to-hip ratio as a predictor of newborn size: results of the Diana Project. Epidemiology. 1996;7:62-66.
McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans. Diabetologia. 1992; 35:785-791.
Fowden AL. The role of insulin in prenatal growth. J Dev Physiol. 1989;12:173-182.
Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med. 2000;9:35-41.
Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol. 2000;43:283-297.
Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989-997.
Ratner RE. Clinical review 47: gestational diabetes mellitus: after three international workshops do we know how to diagnose and manage it yet? J Clin Endocrinol Metab. 1993;77:1-4.
Jarrett RJ. Gestational diabetes: a non-entity? Brit Med J. 1993;306:37-38.
Buchanan TA, Kjos SL. Gestational diabetes: risk or myth? J Clin Endocrinol Metab. 1999;84:1854-1857.
Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341:1749-1756.
Dornhorst A, Chan SP. The elusive diagnosis of gestational diabetes. Diabet Med. 1998;15:7-10.
Ferrara A, Hedderson MM, Quesenberry CP, Selby JV. Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds. Diabetes Care. 2002;25:1625-1630.
Sermer M, Naylor CD, Gare DJ. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol. 1995;173:146-156.
Leikin EL, Jenkins JH, Pomerantz GA, Klein L. Abnormal glucose screening tests in pregnancy: a risk factor for fetal macrosomia. Obstet Gynecol. 1987;69:570-573.
Yogev Y, Langer O, Xenakis EM, Rosenn B. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women. J Matern Fetal Neonatal Med. 2005;17:29-34.
Hill JC, Krishnaveni GV, Annamma I, Leary SD, Fall CH. Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry. Acta Obstet Gynecol Scand. 2005;84:159-165.
Farmer G, Russell G, Hamilton-Nicol DR. The influence of maternal glucose metabolism on fetal growth, development and morbidity in 917 singleton pregnancies in nondiabetic women. Diabetologia. 1988;31:134-141.
The HAPOStudy Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. New Engl J Med. 2008;358:1991-2002.
Rey E, Attie C, Bonin A. The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol. 1999;181:202-206.
Illsley NP. Glucose transporters in the human placenta. Placenta. 2000;21:14-22.
Illsley NP. Placental glucose transport in diabetic pregnancy. Clin Obstet Gynecol. 2000;43:116-126.
Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999;84:695-701.
Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71:1256S-1261S.
Di Cianni G, Miccoli R, Volpe L. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med. 2005;22:21-25.
Bo S, Menato G, Gallo ML. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand. 2004;83:335-340.
Nolan CJ, Proietto J. The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia. 1994;37:976-984.
Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T. Maternal serum triglyceride at 24–32 weeks’ gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol. 2001;97:776-780.
Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care. 1992;15:1605-1613.
Peterson CM, Jovanovic-Peterson L, Mills JL. The Diabetes in Early Pregnancy Study: changes in cholesterol, triglycerides, body weight, and blood pressure. The National Institute of Child Health and Human Development–the Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1992;166:513-518.
Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165:914-919.
Cousins L. Insulin sensitivity in pregnancy. Diabetes. 1991;40(suppl 2):39-43.
Barbour LA. New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring. J Obstet Gynaecol. 2003;23:545-549.
Catalano PM, Tyzbir ED, Wolfe RR, Roman NM, Amini SB, Sims EA. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol. 1992;167:913-919.
Catalano PM, Tyzbir ED, Wolfe RR. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993;264:E60-E67.
Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991; 165:1667-1672.
Kirwan JP, Hauguel-De MS, Lepercq J. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207-2213.
Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971-1977.
Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? Diab Care. 1999;22(suppl 3):C25-C30.
Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab. 2002;87:4231-4237.
Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab. 2003; 88:3507-3512.
Ramsay JE, Stewart F, Greer IA, Sattar N. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG. 2003;110:1029-1031.
Forsen T, Eriksson JG, Tuomilehto J, Teramo K, Osmond C, Barker DJ. Mother’s weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. Brit Med J. 1997;315:837-840.
Dahlgreen J, Nilsson C, Jennische E, et al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab. 2001;281:E326–E334.
Pettitt DJ, Knowler WC. Diabetes and obesity in the Pima Indians: a crossgenerational vicious cycle. J Obesity Weight Regul. 1988;7:61-65.
Pettitt DJ, Knowler WC, Bennett PH, Aleck KA, Baird HR. Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care. 1987;10:76-80.
Harder T, Kohlhoff R, Dorner G, Rohde W, Plagemann A. Perinatal ‘programming’ of insulin resistance in childhood: critical impact of neonatal insulin and low birth weight in a risk population. Diabet Med. 2001;18:634-639.
Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers: Relationship to fetal hyperinsulinism. Diabetes Care. 1995; 18:611-617.
Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH. Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care. 2000;23:905-911.
Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care. 1993;16:310-314.
Pettitt DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. New Engl J Med. 1983;308:242-245.
Pettitt DJ, Bennett PH, Knowler WC, Baird HR, Aleck KA. Gestational diabetes mellitus and impaired glucose tolerance during pregnancy. Long-term effects on obesity and glucose tolerance in the offspring Diabetes. 1985;34(suppl 2):119-122.
Silverman BL, Rizzo T, Green OC. Long-term prospective evaluation of offspring of diabetic mothers. Diabetes. 1991;40(suppl 2):121-125.
Gillman MW, Rifas-Shiman S, Berkey CS, Field AE, Colditz GA. Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics. 2003;111:e221-e226.
Whitaker RC, Pepe MS, Seidel KD, Wright JA, Knopp RH. Gestational diabetes and the risk of offspring obesity. Pediatrics. 1998;101:E 91-E 97.
Dabelea D, Pettitt DJ. Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab. 2001;14:1085-1091.
Dabelea D, Hanson RL, Lindsay RS. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208-2211.
Dabelea D, Mayer-Davis EJ, Lamichhane AP. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diab Care. 2008;31:1422-1426.
Pildes RS, Hart RJ, Warrner R, Cornblath M. Plasma insulin response during oral glucose tolerance tests in newborns of normal and gestational diabetic mothers. Pediatrics. 1969;44:76-83.
Van Assche FA, Gepts W. The cytological composition of the foetal endocrine pancreas in normal and pathological conditions. Diabetologia. 1971;7:434-444.
Heding LG, Persson B, Stangenberg M. B-cell function in newborn infants of diabetic mothers. Diabetologia. 1980;19:427-432.
Gautier JF, Wilson C, Weyer C. Low acute insulin secretory responses in adult offspring of people with early onset type 2 diabetes. Diabetes. 2001;50:1828-1833.
Holemans K, Gerber RT, Meurrens K, De Clerck F, Poston L, Van Assche FA. Streptozotocin diabetes in the pregnant rat induces cardiovascular dysfunction in adult offspring. Diabetologia. 1999;42:81-89.
Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia. 2002;45:991-996.
Bunt JC, Tataranni PA, Salbe AD. Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children. J Clin Endocrinol Metab. 2005;90:3225-3229.
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-2486.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Dabelea, D. (2010). The Diabetic Intrauterine Environment: Short and Long-Term Consequences. In: Kim, C., Ferrara, A. (eds) Gestational Diabetes During and After Pregnancy. Springer, London. https://doi.org/10.1007/978-1-84882-120-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-84882-120-0_16
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-119-4
Online ISBN: 978-1-84882-120-0
eBook Packages: MedicineMedicine (R0)